Physician profile
Sereen Askar
NPI 1104377555
$1,418.81
in general payments reported to CMS, 2019-2025
18 companies · $20.59 in 2025
The $20.59 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $333 · 2022: $547 · 2023: $466 · 2024: $51.69 · 2025: $20.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $240.58 | 2021-2023 | Nourianz |
| Mdd US Operations, LLC | $224.76 | 2022-2023 | Xadago, Apokyn |
| Abbvie INC. | $163.56 | 2021-2023 | |
| Ucb, INC. | $111.51 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $102.25 | 2022-2025 | Ongentys, Ingrezza |
| Eisai INC. | $85.78 | 2023 | |
| Acorda Therapeutics, INC | $78.80 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $78.40 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $51.69 | 2024 | |
| Medtronic, INC. | $45.00 | 2022 | |
| Ge Healthcare | $44.99 | 2022-2023 | |
| Jazz Pharmaceuticals INC. | $43.15 | 2022 | |
| Boston Scientific Corporation | $40.16 | 2021-2022 | |
| Sk Life Science, INC. | $39.91 | 2021 | |
| Acadia Pharmaceuticals INC | $17.88 | 2023 | Nuplazid |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $17.65 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $17.60 | 2021 | |
| Upsher-Smith Laboratories LLC | $15.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sereen Askar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.